Saif, Muhammad. 2014. “MM-398 Achieves Primary Endpoint of Overall Survival in Phase III Study in Patients With Gemcitabine Refractory Metastatic Pancreatic Cancer”. JOP. Journal of the Pancreas 15 (3), 278-79. https://doi.org/10.6092/1590-8577/2507.